Diana Malaeb1, Youssef Farchakh2, Chadia Haddad3,4, Hala Sacre5, Sahar Obeid3,5,6, Souheil Hallit2,5, Pascale Salameh5,7,8. 1. School of Pharmacy, Lebanese International University, Beirut, Lebanon. 2. Faculty of Medicine and Medical Sciences, Holy Spirit University of Kaslik (USEK), Jounieh, Lebanon. 3. Research Department, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon. 4. Tropical Neuroepidemiology, Institute of Tropical Epidemiology and Neurology, GEIST, University of Limoges, Limoges, France. 5. INSPECT-LB: National Institute of Public Health, Clinical Epidemiology and Toxicology, Beirut, Lebanon. 6. Faculty of Arts and Sciences, Holy Spirit University of Kaslik (USEK), Jounieh, Lebanon. 7. Faculty of Pharmacy, Lebanese University, Hadat, Lebanon. 8. University of Nicosia Medical School, Nicosia, Cyprus.
Abstract
PURPOSE: To develop and validate a short version of the Beirut Distress Scale (BDS-22), the BDS-10, in the Lebanese population, and evaluate the association between psychological distress and other mental disorders. METHODS: A total of 2260 participants was enrolled in this cross-sectional study (January-July 2019). RESULTS: Items converged over a solution of two factors (Factor 1 = Mood, affect and cognitive symptoms; Factor 2 = Physical symptoms; total variance explained = 64.51%). A significantly high correlation was found between BDS-10 and BDS-22 (r = 0.963, p < 0.001). Higher depression, anxiety, and insomnia were significantly associated with higher stress (higher BDS-10 and BDS-22 scores). PRACTICE IMPLICATIONS: This new short tool is valid and reliable to screen for psychological distress, influencing mood and affect, and physical and cognitive functions.
PURPOSE: To develop and validate a short version of the Beirut Distress Scale (BDS-22), the BDS-10, in the Lebanese population, and evaluate the association between psychological distress and other mental disorders. METHODS: A total of 2260 participants was enrolled in this cross-sectional study (January-July 2019). RESULTS: Items converged over a solution of two factors (Factor 1 = Mood, affect and cognitive symptoms; Factor 2 = Physical symptoms; total variance explained = 64.51%). A significantly high correlation was found between BDS-10 and BDS-22 (r = 0.963, p < 0.001). Higher depression, anxiety, and insomnia were significantly associated with higher stress (higher BDS-10 and BDS-22 scores). PRACTICE IMPLICATIONS: This new short tool is valid and reliable to screen for psychological distress, influencing mood and affect, and physical and cognitive functions.